Matthew Steven Davids, MD, MMSc, on Venetoclax Plus R-EPOCH to Treat Richter ’s Syndrome

The CLL expert discussed the possibility of venetoclax plus dose-adjusted R-EPOCH becoming a new treatment approach in patients with CLL who developed Richter ’s Syndrome.

Source: CancerNetwork - June 1, 2020 Category: Cancer & Oncology Authors: Matthew Steven Davids, MD, MMSc Source Type: news